Role of endocannabinoid system in the pathogenesis of obesity: how can we help a patient? From theory to practice
Obesity that results in various metabolic disorders is one of the central concerns of modern healthcare system. Only 4% to 5% of patients with metabolic syndrome achieve favorable outcomes without any additional pharmacotherapy. Therefore, many patients require weight-loss drugs in addition to non-p...
Saved in:
Published in | РМЖ: Медицинское обозрение Vol. 4; no. 6; pp. 382 - 389 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!